| Bid Price | High Price | ||
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2017 | 1,501.00 | 1,501.00 | 1,485.50 | 1,490.00 | 8,201,957 |
| Aug 17, 2017 | 1,503.00 | 1,512.19 | 1,502.50 | 1,506.00 | 5,962,543 |
| Aug 16, 2017 | 1,498.50 | 1,528.91 | 1,497.12 | 1,504.00 | 6,396,087 |
| Aug 15, 2017 | 1,483.00 | 1,500.00 | 1,483.50 | 1,494.50 | 5,088,890 |
| Aug 14, 2017 | 1,480.50 | 1,483.81 | 1,470.69 | 1,480.50 | 6,462,470 |
| Company Name | GlaxoSmithKline | Epic | GSK |
|---|---|---|---|
| ISIN | GB0009252882 | Index | FTSE 100 |
| EMS | 1,500 | Prev Close | 1,479.50 |
| Shares in Issue (m) | 4,918.48 | Market Cap (£m) | 73,285.33 |
| PE Ratio | 79.26 | Div per Share (p) | 80.00 |
| Div Yield | 5.37 | Div Cover | 0.24 |
| EPS | 18.80 | EPS Growth (%) | -89.21 |
| PEG | -0.89 | DPS Growth (%) | 0.00 |
| ROCE | 4.84 | Net Gearing | 83.31 |
| Quick Ratio | 0.61 | Current Ratio | 0.88 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 09 Aug | Berenberg | Buy | 1,479.50 | 1,885.00 | 1,835.00 | Reiterates |
| 07 Aug | Deutsche Bank | Hold | 1,479.50 | 1,720.00 | 1,610.00 | Retains |
| 31 Jul | Kepler Cheuvreux | Reduce | 1,479.50 | 1,520.00 | 1,520.00 | Reiterates |
| 28 Jul | Shore Capital | Hold | 1,479.50 | - | - | Retains |
| 27 Jul | Barclays Capital | Equal weight | 1,479.50 | 1,550.00 | 1,550.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 26 Jul 2017 | Sir Roy Anderson | Buy | 567 @ 1,599.00p | £9,066.33 |
| 26 Jul 2017 | Sir Philip Hampton | Buy | 2,736 @ 1,599.00p | £43,748.64 |
| 26 Jul 2017 | Urs Rohner | Buy | 567 @ 1,599.00p | £9,066.33 |
| 26 Jul 2017 | Manvinder Banga | Buy | 2,267 @ 1,599.00p | £36,249.33 |
| 26 Jul 2017 | Dr Vivienne Cox | Buy | 449 @ 1,599.00p | £7,179.51 |
